Published in Neurobiol Aging on December 03, 1996
Early Markers of Cognitive Change and Alzheimer s Disease | NCT01867346
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans. Brain Pathol (2011) 2.11
Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11
Differential FDDNP PET patterns in nondemented middle-aged and older adults. Am J Geriatr Psychiatry (2009) 1.62
Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol (2008) 1.49
Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging (2007) 1.34
Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry (2001) 1.30
Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol (2010) 1.29
Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review. BMC Neurol (2006) 1.27
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest (2009) 1.23
Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA). J Alzheimers Dis (2009) 1.15
Cognitive and social lifestyle: links with neuropathology and cognition in late life. Acta Neuropathol (2013) 1.05
Asymptomatic Alzheimer's disease: a prodrome or a state of resilience? Curr Alzheimer Res (2011) 1.05
The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage (2013) 1.05
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement. Curr Opin Neurol (2012) 1.04
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. J Alzheimers Dis (2011) 1.03
Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J Alzheimers Dis (2010) 1.02
Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiol Aging (2011) 0.99
Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease. Neuromolecular Med (2008) 0.98
Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J Neurochem (2000) 0.95
Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology (2009) 0.94
Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. J Neuropathol Exp Neurol (2014) 0.89
Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? Parkinsonism Relat Disord (2011) 0.88
Age and apoE associations with complex pathologic features in Alzheimer's disease. J Neurol Sci (2008) 0.87
Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age. Cogn Behav Neurol (2015) 0.83
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol (2016) 0.83
Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease. J Clin Invest (1999) 0.83
Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol (2014) 0.80
Longitudinal brain activity changes in asymptomatic Alzheimer disease. Brain Behav (2012) 0.80
Quantization and analysis of hippocampal morphometric changes due to dementia of Alzheimer type using metric distances based on large deformation diffeomorphic metric mapping. Comput Med Imaging Graph (2011) 0.80
Antemortem Prediction of Braak Stage. J Neuropathol Exp Neurol (2015) 0.78
Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology. Neurobiol Aging (2016) 0.77
Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders. Ageing Res Rev (2016) 0.75
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging. Int J Geriatr Psychiatry (2012) 0.75
What does it take to stay healthy past 100?: Commentary on "No disease in the brain of a 115-year-old woman". Neurobiol Aging (2008) 0.75
APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study. Oncotarget (2015) 0.75
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet (1997) 7.15
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A (1996) 4.16
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med (1992) 3.71
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol (1995) 3.66
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A (1990) 3.13
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol (1997) 2.43
Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev (2001) 2.35
The association of breast mitogens with mammographic densities. Br J Cancer (2002) 2.25
Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11
Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci (1997) 2.01
Elevation of serum copper levels in Alzheimer's disease. Neurology (2002) 1.93
Prevalence of dementia after age 90: results from the 90+ study. Neurology (2008) 1.88
Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology (2005) 1.86
Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat Med (1997) 1.86
Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer (2008) 1.83
Evidence for linkage on 21q and 7q in a subset of autism characterized by developmental regression. Mol Psychiatry (2005) 1.83
The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab (2001) 1.82
Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol (1996) 1.80
Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep (2001) 1.78
Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74
Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis (2001) 1.72
Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (1995) 1.71
Biochemical characterization and localization of a non-N-methyl-D-aspartate glutamate receptor in rat brain. J Neurochem (1992) 1.58
Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol (1997) 1.57
Mammographic densities and breast cancer risk. Breast Dis (1998) 1.49
Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci (2000) 1.49
Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer (2003) 1.48
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology (2008) 1.45
Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci (1996) 1.44
Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci (2001) 1.41
On the predictability of violent behavior: considerations and guidelines. J Forensic Sci (1991) 1.38
Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol (1997) 1.34
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology (2006) 1.31
Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J Clin Invest (1997) 1.31
Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev (1999) 1.24
Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev (1996) 1.24
Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann Neurol (1998) 1.23
Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as "continuum" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience (2007) 1.23
Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ (2001) 1.22
A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer (1993) 1.20
Heritability of obesity-related traits among Nigerians, Jamaicans and US black people. Int J Obes Relat Metab Disord (2001) 1.20
Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J Neurochem (1995) 1.19
The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain. J Neurosci (1992) 1.18
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res Mol Brain Res (1994) 1.18
Osmotically induced retinal detachment in the rabbit and primate. Electron miscoscopy of the pigment epithelium. Invest Ophthalmol Vis Sci (1980) 1.18
N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci (2001) 1.18
Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience (1997) 1.17
Changes in immediate visual memory predict cognitive impairment. Arch Clin Neuropsychol (1995) 1.17
Simultaneous measurement of plasma concentrations and 13C-enrichment of short-chain fatty acids, lactic acid and ketone bodies by gas chromatography coupled to mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.16
N-methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J Neurochem (1996) 1.13
Searching for genes underlying normal variation in human adiposity. J Mol Med (Berl) (2001) 1.11
Neurodegeneration in the thalamus following neonatal hypoxia-ischemia is programmed cell death. Dev Neurosci (2001) 1.07
Conversion from mild cognitive impairment to Alzheimer's disease is predicted by sources and coherence of brain electroencephalography rhythms. Neuroscience (2006) 1.07
Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J Neurol Sci (2000) 1.05
Aging and the public health effects of dementia. N Engl J Med (2001) 1.05
Insulin resistance and arterial stiffness in healthy adolescents and young adults. Diabetologia (2011) 1.05
Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obes Rev (2007) 1.05
The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann N Y Acad Sci (2000) 1.04
The detection of change in mammographic density. Cancer Epidemiol Biomarkers Prev (2003) 1.03
Mammographic densities and risk of breast cancer among subjects with a family history of this disease. J Natl Cancer Inst (1999) 1.03
Cognitive decline strongly correlates with cortical atrophy in Alzheimer's dementia. Neurobiol Aging (1999) 1.03
Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience (2012) 1.00
APOE genotype and survival in men and women with Alzheimer's disease. Neurology (2002) 0.97
Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience (2005) 0.97
Quantitative and qualitative changes in AMPA receptor expression during spinal cord development. Neuroscience (1995) 0.96
Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest. J Cereb Blood Flow Metab (1999) 0.96
Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am J Pathol (1998) 0.95
Fimbria-fornix transections selectively down-regulate subtypes of glutamate transporter and glutamate receptor proteins in septum and hippocampus. J Neurochem (1996) 0.95
In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol (1996) 0.94
Comparison of polymerase chain reaction and microbiological culture for detection of salmonellae in equine feces and environmental samples. Am J Vet Res (1996) 0.93
Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice. Am J Pathol (2001) 0.93
Intraocular endoscopic surgery. Am J Ophthalmol (1981) 0.92
INSIG1 influences obesity-related hypertriglyceridemia in humans. J Lipid Res (2009) 0.92
Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol (1995) 0.90
Age-associated inclusions in normal and transgenic mouse brain. Science (1992) 0.90
Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes. Proc Natl Acad Sci U S A (2004) 0.90
MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome. Mucosal Immunol (2012) 0.90
Nitric oxide synthase 1 and nitric oxide synthase 3 protein expression is regionally and temporally regulated in fetal brain. Brain Res Dev Brain Res (1996) 0.90
Lack of association of the apoE4 allele with hippocampal sclerosis dementia. Neurosci Lett (1996) 0.90
Failure to sustain recovery of Na,K-ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets. Brain Res Mol Brain Res (2001) 0.89
'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm (Vienna) (2007) 0.89
Gastrointestinal parasites of swine in Québec. I. An incidence survey. Can Vet J (1974) 0.89
Effects of a low-fat high-carbohydrate diet on plasma sex hormones in premenopausal women: results from a randomized controlled trial. Canadian Diet and Breast Cancer Prevention Study Group. Br J Cancer (1997) 0.89
Record review of baboons with histologically confirmed endometriosis in a large established colony. J Med Primatol (2003) 0.89
Aged non-human primates: an animal model of age-associated neurodegenerative disease. Brain Pathol (1991) 0.89
Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo. Neuroscience (2005) 0.89
Long-term effects of participation in a randomized trial of a low-fat, high-carbohydrate diet. Cancer Epidemiol Biomarkers Prev (1996) 0.88
Topographic, non-collateralized basal forebrain projections to amygdala, hippocampus, and anterior cingulate cortex in the rhesus monkey. Brain Res (1988) 0.88
Lack of relation between race and cognitive test performance in Alzheimer's disease. Neurology (1998) 0.88
Projection neurons and interneurons in the lateral geniculate nucleus undergo distinct forms of degeneration ranging from retrograde and transsynaptic apoptosis to transient atrophy after cortical ablation in rat. Neuroscience (2002) 0.88
Thalamic neuron apoptosis emerges rapidly after cortical damage in immature mice. Neuroscience (2002) 0.88
Familial resemblance of body composition in prepubertal girls and their biological parents. Am J Clin Nutr (2001) 0.88
Occipital cortex ablation in adult rat causes retrograde neuronal death in the lateral geniculate nucleus that resembles apoptosis. Neuroscience (1998) 0.87
Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. Horm Res (2007) 0.87
Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia. Neurology (2003) 0.87
Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol Biomarkers Prev (1995) 0.86
Ontogeny of non-NMDA glutamate receptors in rat barrel field cortex: I. Metabotropic receptors. J Comp Neurol (1997) 0.86